BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21247435)

  • 1. Plasma lipoprotein-associated phospholipase A2 in patients with metabolic syndrome and carotid atherosclerosis.
    Gong HP; Du YM; Zhong LN; Dong ZQ; Wang X; Mao YJ; Lu QH
    Lipids Health Dis; 2011 Jan; 10():13. PubMed ID: 21247435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of lipoprotein-associated phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis.
    Vickers KC; Maguire CT; Wolfert R; Burns AR; Reardon M; Geis R; Holvoet P; Morrisett JD
    J Lipid Res; 2009 Sep; 50(9):1735-43. PubMed ID: 19359705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carotid intima media thickness is associated with plasma lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in patients with type 2 diabetes.
    Constantinides A; van Pelt LJ; van Leeuwen JJ; de Vries R; Tio RA; van der Horst IC; Sluiter WJ; Dullaart RP
    Eur J Clin Invest; 2011 Aug; 41(8):820-7. PubMed ID: 21281278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.
    Ueshima H; Kadowaki T; Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Sekikawa A; Kadota A; Kadowaki S; Nakamura Y; Miyagawa N; Okamura T; Kita Y; Takashima N; Kashiwagi A; Maegawa H; Horie M; Yamamoto T; Kimura T; Kita T;
    Atherosclerosis; 2016 Mar; 246():141-7. PubMed ID: 26775119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques.
    Mannheim D; Herrmann J; Versari D; Gössl M; Meyer FB; McConnell JP; Lerman LO; Lerman A
    Stroke; 2008 May; 39(5):1448-55. PubMed ID: 18356547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of lipoprotein-associated phospholipase A(2) are increased in patients with β-thalassemia.
    Tselepis AD; Hahalis G; Tellis CC; Papavasiliou EC; Mylona PT; Kourakli A; Alexopoulos DC
    J Lipid Res; 2010 Nov; 51(11):3331-41. PubMed ID: 20625038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profile.
    Dullaart RP; Constantinides A; Perton FG; van Leeuwen JJ; van Pelt JL; de Vries R; van Tol A
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1077-84. PubMed ID: 21252249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of lipoprotein-associated phospholipase A(2) and endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Garg PK; McClelland RL; Jenny NS; Criqui M; Liu K; Polak JF; Jorgensen NW; Cushman M
    Vasc Med; 2011 Aug; 16(4):247-52. PubMed ID: 21708876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein-associated phospholipase A2 (Lp-PLA2) and tumor necrosis factor-alpha (TNF-α) and their relation to premature atherosclerosis in β-thalassemia children.
    Ragab SM; Safan MA; Obeid OM; Sherief AS
    Hematology; 2015 May; 20(4):228-38. PubMed ID: 25056687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of lipoprotein-associated phospholipase A₂ activity with components of the metabolic syndrome in apparently healthy boys.
    Hirschler V; Meroño T; Maccallini G; Gomez Rosso L; Aranda C; Brites F
    Cardiovasc Hematol Agents Med Chem; 2011 Apr; 9(2):78-83. PubMed ID: 21476960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-Associated Phospholipase A2 and Risk of Carotid Atherosclerosis and Cardiovascular Events in Community-Based Older Adults in China.
    Wang C; Fang X; Hua Y; Liu Y; Zhang Z; Gu X; Wu X; Tang Z; Guan S; Liu H; Liu B; Guo X; Ji X
    Angiology; 2018 Jan; 69(1):49-58. PubMed ID: 28429599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Lp-PLA2 with digital reactive hyperemia, coronary flow reserve, carotid atherosclerosis and arterial stiffness in coronary artery disease.
    Ikonomidis I; Kadoglou NN; Tritakis V; Paraskevaidis I; Dimas K; Trivilou P; Papadakis I; Tzortzis S; Triantafyllidi H; Parissis J; Anastasiou-Nana M; Lekakis J
    Atherosclerosis; 2014 May; 234(1):34-41. PubMed ID: 24594367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of intima-media thickness of carotid artery and lipoprotein-associated phospholipase A2 in coronary heart diseases of different types.
    Li Y
    Technol Health Care; 2015; 23 Suppl 1():S147-50. PubMed ID: 26410317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The Tromsø study.
    Herder M; Arntzen KA; Johnsen SH; Mathiesen EB
    Cardiovasc Diabetol; 2012 Jun; 11():77. PubMed ID: 22738646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of lipoprotein-associated phospholipase A(2) in the metabolic syndrome and diabetes.
    Noto H; Chitkara P; Raskin P
    J Diabetes Complications; 2006; 20(6):343-8. PubMed ID: 17070436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
    Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
    Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-associated phospholipase A2 and measures of extracoronary atherosclerosis: the Rotterdam Study.
    Kardys I; Oei HH; van der Meer IM; Hofman A; Breteler MM; Witteman JC
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):631-6. PubMed ID: 16373603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lipoprotein-associated phospholipase A2 predicts the formation of carotid artery plaque and its vulnerability in anterior circulation cerebral infarction.
    Yang Y; Xue T; Zhu J; Xu J; Hu X; Wang P; Kong T; Yan Y; Yang L; Xue S
    Clin Neurol Neurosurg; 2017 Sep; 160():40-45. PubMed ID: 28644968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis.
    Zhong M; Tan HW; Gong HP; Wang SF; Zhang Y; Zhang W
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):878-84. PubMed ID: 18363885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
    Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
    Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.